Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Deau-Fisher
Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
PLoS ONE
Multidisciplinary
Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Distinction Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma With C-Myc Rearrangement
Modern Pathology
Forensic Medicine
Pathology
P53 Expression Correlates With Poorer Survival and Augments the Negative Prognostic Effect of MYC Rearrangement, Expression or Concurrent MYC/BCL2 Expression in Diffuse Large B-Cell Lymphoma
Modern Pathology
Forensic Medicine
Pathology
Detailed Molecular Analysis and Evaluation of Prognosis in Cases With High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
British Journal of Haematology
Hematology
Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
C-Myc and BCL2: Correlation Between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma
Asian Pacific Journal of Cancer Prevention
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology